印楝素A和印楝素B对棉铃虫生长发育的影响

为了明确印楝素A和印楝素B生物活性的差异,选用印楝素A和印楝素B对棉铃虫生长发育的影响进行了比较研究。结果表明:印楝素A和印楝素B对棉铃虫3龄幼虫具有良好的拒食活性,5μg/mL处理48 h对棉铃虫3龄幼虫的拒食率分别为85.17%和69.02%。分别用含有药剂(1μg/mL)的饲料饲喂棉铃虫5龄幼虫,结果表明:印楝素A和印楝素B能够明显抑制棉铃虫5龄幼虫的体重增长,处理14 d后幼虫的体重分别下降50.28%和43.08%,仅有少量个体化蛹,化蛹率分别为26.67%和13.33%。进一步的羽化结果表明:经印楝素A和印楝素B处理的虫蛹均未能完成羽化。综合各阶段试验结果来看,印楝素A和印楝素B的生物活性存在差异,印楝素B对棉铃虫生长发育的抑制作用高于印楝素A。     

印楝素乳油对斜纹夜蛾的生物活性及田间防效研究

在室内测定了印楝素乳油对斜纹夜蛾(Spodopteralitura)的生物活性,并进行了田间防治试验.结果表明,印楝素乳油对斜纹夜蛾具有多种生物活性,主要表现在对幼虫的拒食作用、生长发育的抑制作用和一定的毒杀活性,以及对成虫产卵的忌避作用.经印楝素处理后,幼虫平均发育历期延长、幼虫体重、蛹重、化蛹率和蛹羽化率显著低于对照,印楝素乳油12μl·L^-1浓度处理3龄幼虫5和7d后的体重分别是对照组的36.8%和14.5%,而幼虫平均发育历期比对照组延长6d左右,化蛹率和蛹羽化率分别是27.79%和37.23%,显著低于对照组85.66%和82.11%.印楝素对低龄幼虫有一定的毒杀活性,而对高龄幼虫活性则很低.田间防治试验表明,印楝素乳油对斜纹夜蛾种群有良好的控制作用,施药7d后其防治效果要优于化学农药10%除尽悬浮剂.     

印楝素A与印楝素B对粉纹夜蛾BTI-Tn-5B1-4的细胞毒性

为了明确印楝素A和B活性差异的机理,本研究比较了印楝素A和印楝素B对粉纹夜蛾Trichoplusia ni离体培养胚胎细胞系BTI-Tn-5B1-4的毒性。结果表明：印楝素A与印楝素B对BTI-Tn-5B1-4细胞具有良好的增殖抑制活性,处理后3 d,其IC₅₀值分别为2.9 μg/mL和9.85 μg/mL,印楝素A的细胞毒力显著高于印楝素B。倒置显微镜观察发现,印楝素A和印楝素B处理可导致细胞变形,贴壁能力下降,并出现明显空泡,印楝素A的影响明显高于印楝素B。流式细胞仪检测结果表明,印楝素可导致BTI-Tn-5B1-4细胞体积显著膨大,印楝素A处理细胞体积增大程度显著高于印楝素B;印楝素可以明显影响BTI-Tn-5B1-4细胞膜电位,1.25 μg/mL印楝素A和印楝素B处理后3 d,细胞DiBAC4（3）荧光强度分别增加88.12%和55.37%,印楝素A的影响显著高于印楝素B。荧光显微镜观察发现,印楝素对BTI-Tn-5B1-4细胞核具有明显影响,印楝素B的影响明显高于印楝素A,印楝素B处理后,细胞核受损细胞数更多,受损程度更严重。结果显示印楝素A和印楝素B的细胞作用机理存在差异,本研究从细胞学水平解释了印楝素的生长发育抑制作用机理。     

印楝素制剂对锈色粒肩天牛成虫和卵的生物活性测定

为了探索锈色粒肩天牛Apriona sivainsoni(Hope)成虫期利用高效低毒的生物药剂防治技术,使用梯度浓度的印楝素制剂处理国槐当年生嫩枝,供锈色粒肩天牛成虫补充营养时取食,以研究其对锈色粒肩天牛成虫胃毒、拒食、产卵量及卵孵化率的影响.结果表明,不同浓度印楝素药液对锈色粒肩天牛均具有一定的生物活性.0.3%印楝素乳油300倍、400倍、500倍、600倍及700倍液处理后第6 d时,成虫的死亡率分别达97.6%,86.0%.73.8%.50.0%和36.1%;拒食作用也比较明显,300倍、400倍液处理的拒食率达到了94.87%和90.22%,取食量显著低于对照,500倍、600倍及700倍液处理的拒食率分别为61.28%、41.54%和37.00%;不同浓度药液均使成虫产卵量、卵的孵化率显著低于对照.表明在锈色粒肩天牛成虫期,在其寄主国槐枝条上喷洒300倍或400倍印楝素乳油能有效防治该天牛成虫.     

獐子菌多糖SIK-1的结构鉴定及其生物活性研究

[目的]探索獐子菌多糖(Sarcodon imbricatus (L. ex Fr.) Karst polysaccharide,SIK-1)的结构及对其调控小鼠免疫细胞和小鼠结肠癌细胞(CT26. WT)生长的影响。[方法]采用核磁共振谱(Nuclear Magnetic Resonance spectroscopy,NMR)检测SIK-1的结构,CCK-8法检测细胞增殖率、抑制率和吞噬率,Elisa试剂盒检测小鼠免疫B细胞分泌抗体Ig A、Ig G、Ig M的分泌率。[结果]SIK-1的1H NMR谱数据显示SIK-1含有α型吡喃糖和β型吡喃糖;13C NMR谱数据显示獐子菌多糖中含有6个糖残基,由3个α型糖残基和3个β型糖残基构成的重复结构单元。SIK-1质量浓度为5μg/m L和10μg/m L时能极显著地促进T细胞、B细胞和RAW264. 7细胞的增殖;且能抑制CT26. WT的生长,且呈一定的剂量关系; SIK-1质量浓度在15μg/m L时能显著促进B细胞分泌免疫因子Ig A、Ig G、Ig M; SIK-1质量浓度为5μg/m L时能显著提高巨噬细胞的吞噬能力。[结论]...     

印楝素A对粉纹夜蛾Hi-5细胞的毒性机理

利用粉纹夜蛾Trichoplusia ni Hübner卵细胞系（Hi-5细胞系）在细胞水平研究了印楝素(azadirachtin) A杀卵活性的毒性机理。以MTT法研究了印楝素A对粉纹夜蛾Hi-5细胞的生长抑制率,结果表明最初两天印楝素 A对Hi-5细胞无较明显活性,但随后几天抑制率显著增加。用Giemsa染色法对细胞进行染色,观察细胞形态发生的变化,发现：1.25 μg/mL印楝素 A处理Hi-5细胞1 d后,细胞已无法贴壁,形状变圆,接着细胞形态变得极不规则,有凋亡小体出现。用Ho33342染料对Hi-5细胞核DNA染色,通过荧光显微镜观察发现：经印楝素A处理后第1天,部分细胞核染色体发生异常凝聚,此后异常细胞核比例增多,核膜严重破损。以异硫氰酸荧光素(FITC)荧光染料研究了Hi-5细胞的蛋白质含量变化,发现1.25 μg/mL印楝素A 处理Hi-5细胞1 d后,细胞蛋白质指数(DI)为1.070±0.018,至第3 d DI值上升到1.912±0.019。分析了印楝素A处理后Hi-5的还原性谷胱甘肽(GSH)的相对含量变化,发现1.25 μg/mL处理浓度下,各天处理组GSH抑制率有显著差异。结果显示印楝素A能够抑制Hi-5细胞增殖,影响细胞骨架正常功能,降低细胞活力。     

稳定表达人ASB12的C2C12细胞系的建立及鉴定

ASB12(homo sapiens ankyrin repeat and SOCS box containing 12)蛋白含有5个ANK(ankyrin repeat sequence)序列和一个保守的SOCS(suppressor of cytokine signaling)盒结构域,是ASBs(human ankyrin repeat andSOCS box containing protein family,ASB family)家族的成员.人类ASB12基因在成体心肌和骨骼肌组织中特异表达,是成肌分化的候选基因.利用阳离子聚合物转染技术将重组表达质粒pCMV-tag2B-ASB12转染小鼠骨骼肌细胞系C2C12细胞,通过G418筛选、免疫荧光检测、RT-PCR分析、Western blotting检测建立了稳定表达ASB12的细胞系C2C12-ASB12,为研究ASB12在骨骼肌发育及其相关功能提供有用的细胞研究模型.     

干扰Sema7A抑制C2C12成肌细胞的增殖和分化

为研究脑信号蛋白家族（Semaphorins）成员Sema7A对成肌细胞增殖和分化的影响,本文设计并合成了Sema7A基因的小干扰RNA（small interfering RNA,siRNA）,用此siRNA转染C2C12成肌细胞．通过Hoechst核染和流式细胞术检测细胞增殖情况,免疫荧光检测肌管的形成情况,real-time qPCR和Western印迹技术检测成肌标记基因的变化.结果显示,干扰Sema7A后,C2C12成肌细胞增殖减慢,处在G2和S期的细胞所占的比例明显下降,而G1期细胞的比例升高．免疫荧光检测结果显示,干扰Sema7A后,肌管的直径及MyHC+细胞所占比例均显著降低．Real-time qPCR和Western印迹结果也显示,肌肉分化标志基因MyoD、MyoG、MyHC的mRNA及蛋白质表达均下降．进一步检测Sema7A受体下游信号通路发现,干扰Sema7A后,其下游信号分子PI3K和AKT的磷酸化水平被下调．以上结果表明,Sema7A可以调节C2C12成肌细胞的增殖和分化,可能是通过其受体作用于PI3K/AKT信号通路实现的,这为进一步研究Sema7A在骨骼肌发育中的作用提供实验基础.     

重组鹅β-防御素12蛋白的原核表达及生物学特性

【目的】研究重组鹅β-防御素12蛋白的原核表达并探究其生物学特性。【方法】采用His标签蛋白原核表达系统,将鹅防御素12(Av BD12)基因亚克隆到表达载体p Pro EX-HTa上,构建重组表达质粒。将重组表达质粒转化到大肠杆菌Rosseta感受态中,用IPTG进行诱导表达,并对该重组蛋白进行纯化。进一步采用菌落计数法测定其体外抗菌活性和盐离子稳定性。【结果】经Tricine-SDS-PAGE电泳分析,诱导表达的鹅Av BD12重组蛋白分子量约为12 k D,大部分以包涵体形式存在。该重组蛋白对大肠杆菌、鸡白痢沙门氏菌、金黄色葡萄球菌、四联球菌、枯草芽孢杆菌均具有抗菌活性,高浓度盐离子显著抑制重组蛋白的抗菌活性。此外,该重组蛋白对鸡红细胞没有溶血活性。【结论】该重组蛋白具有广谱抗菌活性,高浓度盐离子显著降低其抗菌活性,且该重组蛋白不具有溶解鸡红细胞的活性。     

一株海洋放线菌的分离鉴定及活性研究

从大连海域20~30 m深处生长的海绵中分离到一株有很高抗菌活性的链霉菌D164。根据培养和显微形态、生理生化数据、16S rRNA基因序列数据分析,菌株D164鉴定为娄彻氏链霉菌(Streptomyces rochei)。对菌株D164发酵产物进行抗农业病原菌、杀虫和除草活性检测,结果表明,菌株D164发酵产物具有很高的抗农业病原菌活性,同时又具有很高的杀虫和除草活性,其活性化合物值得进一步研究。     

牛α-IFN及FMDV P12A3C双表达载体的构建及其在BHK-21细胞中的表达

从口蹄疫病毒Asia I/Jiangsu毒株的细胞毒中提取总RNA,通过RT-PCR方法分别获得FMDV的P12A及3C基因;同时以pMD18-T-α-IFN质粒为模板,PCR扩增得到α-IFN基因.将α-IFN基因及FMDV P12A及3C基因连接至双启动子表达载体pBudCE4.1上,构建成双效表达质粒pBudCE4.1-α-IFN-P12A3C,经电泳、PCR、双酶切和DNA测序鉴定表明双效质粒载体构建成功.用此重组质粒转染BHK-21细胞后并对其表达情况进行检测,表明该双表达质粒在BHK-21细胞中能够成功表达.以此重组质粒免疫乳鼠后12 h,按100 TCID50/O.1 mL的量进行攻毒,结果发现该质粒能够抑制病毒的增殖,对乳鼠有一定的保护作用.结果表明成功构建了牛α-IFN及FMDV P12A3C组合基因双表达载体,为进一步研究口蹄疫基因疫苗提供前期基础.     

Bortezomib inhibits C2C12 growth by inducing cell cycle arrest and apoptosis

Proteosome inhibitors such as bortezomib (BTZ) have been used to treat muscle wasting in animal models. However, direct effect of BTZ on skeletal muscle cells has not been reported. In the present study, our data showed that C2C12 cells exhibited a dose-dependent decrease in cell viability in response to increasing concentrations of BTZ. Consistent with the results of cell viability, Annexin V/PI analysis showed a significant increase in apoptosis after exposing the cells to BTZ for 24 h. The detection of cleaved caspase-3 further confirmed apoptosis. The apoptosis induced by BTZ was associated with reduced expression of p-ERK. Cell cycle analysis revealed that C2C12 cells underwent G2/M cell cycle arrest when incubated with BTZ for 24 h. Furthermore, BTZ inhibited formation of multinucleated myotubes. The inhibition of myotube formation was accompanied by decreased expression of Myogenin. Our data suggest that BTZ induces cell death and inhibits differentiation of C2C12 cells at clinically relevant doses.     

Constant expression of mouse calpastatin isoforms during differentiation in myoblast cell line, C2C12

C2C12 is a myoblast cell line which is used to studydifferentiation into multinucleated cells in vitro. Addition of calpain inhibitors, calpeptin orE-64d, to the culture medium prevented the myoblasticfusion of C2C12 cells. Immunoblot studies usingaffinity-purified antibody, revealed that the expressedlevels of mouse calpastatin remained unaltered duringC2C12 cell fusion. The detected calpastatin migratedas a protein of 130 kDa on SDS-polyacrylamide gelelectrophoresis. The estimated molecular mass wassomewhat greater than that in mouse liver anderythrocytes, and much greater than that reported inrat myoblasts. The 130 kDa isoform may contain anadditional N-terminal region designated XL domainfound in bovine calpastatin.     

ZnO nanoparticles augment ALT,AST, ALP and LDH expressions in C2C12 cells

The present study aimed to investigate the effect of ZnO nanoparticles on alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) enzyme expressions in C2C12 cells. ZnO nanoparticles are widely used in the several cosmetic lotions and other biomedical products. Several studies report on ZnO nanoparticle mediated cytotoxicity. However, there are no reports on the effect of ZnO nanoparticles on ALT, AST, ALP and LDH enzyme expressions in C2C12 cells. A cytotoxicity assay was carried out to determine the effect of ZnO nanoparticles (1–5 mg/ml) on C2C12 cell viability at 48 and 72 h. ZnO nanoparticles increased ALT, AST, ALP and LDH enzyme mRNA expression and their activities in C2C12 cells. In conclusion, the present study showed that ZnO nanoparticles increased these enzyme activities and its mRNA expression in C2C12 cells in a dose-dependent manner.     

Constitutive overexpression of the integral membrane protein Itm2A enhances myogenic differentiation of C2C12 cells

Integral membrane protein 2A (Itm2A) is a transmembrane protein belonging to a family composed of at least two other members, Itm2B and Itm2C, all of them having a different expression pattern. The protein serves as a marker for early stages in chondrogenesis and T-cell development. Itm2A is also highly expressed in skeletal muscle. In order to understand the role of Itm2A in muscle development, we constitutively overexpressed exogenous Itm2A in C2C12 myoblast cells. Several clones expressing high levels of Itm2a were isolated and characterized. Overexpression was associated with enhanced tube formation and the appearance of multinuclear cells. Gene expression analysis demonstrated that muscle creatin kinase was upregulated in the presence of exogenous Itm2A. Interestingly, proliferation rates were not altered in the undifferentiated myoblast C2C12 cells. These results demonstrate that overexpression of Itm2a in C2C12 enhances myogenic differentiation in vitro.     

Purification and partial characterization of canine S100A12

Canine S100A12 (cS100A12) is a calcium-binding protein of the S100 superfamily of EF-hand proteins, and its expression is restricted to neutrophils and monocytes. Interaction of S100A12 with the receptor for advanced glycation end products (RAGE) has been suggested to play a central role in inflammation. Moreover, S100A12 has been shown to represent a sensitive and specific marker for gastrointestinal inflammation in humans. Only human, porcine, bovine, and rabbit S100A12 have been purified to date, and an immunoassay for the quantification of S100A12 is available only for humans. Therefore, the aim of this study was to develop a protocol for the purification of S100A12 and to partially characterize this protein in the dog (Canis lupus familiaris) as a prelude to the development of an immunologic method for its detection and quantification in canine serum and fecal specimens. Leukocytes were isolated from canine whole blood by dextran sedimentation, and canine S100A12 was extracted from the cytosol fraction of these cells. Further purification of cS100A12 comprised of ammonium sulfate precipitation, hydrophobic interaction chromatography, and strong cation- and anion-exchange column chromatography. Canine S100A12 was successfully purified from canine whole blood. The relative molecular mass of the protein was estimated at 10,379.5 and isoelectric focusing revealed an isoelectric point of 6.0. The approximate specific absorbance of cS100A12 at 280 nm was determined to be 1.78 for a 1 mg/ml solution. The N-terminal AA sequence of the first 15 residues of cS100A12 was Thr-Lys-Leu-Glu-Asp-His-X-Glu-Gly-Ile-Val-Asp-Val-Phe-His, and revealed 100% identity with the predicted protein sequence available through the canine genome project. Sequence homology for the 14 N-terminal residues identified for cS100A12 with those of feline, bovine, porcine, and human S100A12 was 78.6%. We conclude that canine S100A12 can be successfully purified from canine whole blood using the described methods.